November 19, 2024

Analysis Maps Broad Semaglutide Eligibility

An estimated 136.8 million U.S. adults are eligible for semaglutide, a number exceeding current eligibility for statins, according to an analysis.

Conexiant

November 12, 2024

Cholesterol Swings: New Dementia Warning Sign

High fluctuations in total cholesterol were associated with a 60% increase in dementia risk, while stable levels showed significantly lower cognitive decline over six years in a study of 9,846 elderly adults.

Conexiant

November 12, 2024

New Data Links GLP-1s to Poststroke Outcomes

Post-stroke patients taking GLP-1 or SGLT2 medications showed a 74% lower mortality risk and 84% lower heart attack risk over 3 years compared to untreated peers.

Conexiant

November 11, 2024

Cardiac Patients Sought Sex Advice, Found Silence

While 76% of cardiac patients reported sexual health affecting their mood and well-being, only 5% received counseling on the topic, according to new survey data presented at AHA Scientific Sessions 2024.

Conexiant

October 29, 2024

Early AKI Intervention Fails to Improve Outcomes

Despite achieving a 33.8% implementation rate of its recommendations versus 24.3% in usual care, a novel kidney action team intervention failed to improve outcomes in 4,003 hospitalized patients with acute kidney injury - highlighting the complex challenge of translating increased diagnostic testing into better clinical results.

Conexiant

June 03, 2024

Improving Sleep Quality in Patients With ADHD

Researchers investigate factors contributing to poor sleep quality in patients with ADHD, according to new findings.

Conexiant

June 21, 2024

Salsalate for T1D Neuropathy: Phase 2 Trial Results

Can an old drug learn new tricks?

Conexiant

June 05, 2024

Do Neighborhood Factors Play a Role in Lung Cancer Aggressiveness?

Investigators have examined whether neighborhood violence may be associated with aggressive lung cancer in Black men, according to new findings presented at the Endocrine Society’s Annual Meeting & Exposition 2024.

Conexiant

September 03, 2024

Wearable AF Screening: More Diagnoses, No Stroke Reduction

Wearable ECG screening boosted AF diagnoses by 52% but failed to reduce stroke hospitalizations in the GUARD-AF trial, challenging assumptions about AF screening's impact on stroke prevention.

Conexiant